GSK3 takes centre stage more than 20 years after its discovery

Biochemical Journal

Volumn 359, Issue 1, 2001, Pages 1-16

  Frame, S ^a   Cohen, P ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cancer; Diabetes; Insulin; Neurodegeneration; Wnt

Indexed keywords

CELLS; ENZYMES; GROWTH KINETICS; INSULIN; METABOLISM; MOLECULAR BIOLOGY;

CELL ADHESION;

BIOCHEMISTRY;

BETA CATENIN; CCAAT ENHANCER BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3; GROWTH FACTOR; HEAT SHOCK PROTEIN; INSULIN; NUCLEAR FACTOR; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TYROSINE; WNT PROTEIN;

ANIMAL EXPERIMENT; APOPTOSIS; CELL ADHESION; CELL CYCLE; CELL DIVISION; ENZYME ANALYSIS; ENZYME BINDING; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; HUMAN; PHYSIOLOGY;

ANIMAL; GLYCOGEN SYNTHASE KINASE 3; HUMAN; SUPPORT, NON-U.S. GOV'T;

EID: 0035477020     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3590001     Document Type: Review

References (147)

1. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation fram cyclic-AMP-dependent protein kinase and phosphorylase kinase
2. Multisite phosphorylation of glycogen synthase. Molecular basis for the substrate specificity of glycogen synthase kinase-3 and casein kinase-II (glycogen synthase kinase-5)
3. Molecular cloning and expression of glycogen synthase kinase-3/factor A
4. cDNA cloning and properties of glycogen synthase kinase-3
5. How does insulin stimulate glycogen synthesis?
6. Glycogen synthase from rabbit skeletal muscle; effect of insulin on the state of phosphorylation of the seven phosphoserine residues in vivo
7. Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor elF-2B
8. Regulation of eukaryotic initiation factor elF2B: Glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin
9. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
10. PDK1, one of the missing links in insulin signal transduction?
11. The development and therapeutic potential of protein kinase inhibitors
12. Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific protein phosphatase PP1G/RGL
13. Organizing glucose disposal: Emerging roles of the glycogen targeting subunits of protein phosphatase-1
14. Phosphorylation of the skeletal muscle glycogen-targetting subunit of protein phosphatase 1 in response to adrenaline in vivo
15. Role of protein kinase B and the MAP kinase cascade in mediating the EGF-dependent inhibition of glycogen synthase kinase 3 in Swiss 3T3 cells
16. The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: Evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf
17. Regulation of glycogen synthesis by amino acids in cultured human muscle cells
18. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A
19. Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3β
20. Wingless signaling acts through zeste-white 3, the Drosophila homolog of glycogen synthase kinase-3, to regulate engrailed and establish cell fate
21. Lithium-induced respecification of pattern in Xenopus laevis embryos
22. Role of glycogen synthase kinase 3β as a negative regulator of dorsoventral axis formation in Xenopus embryos
23. Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos
24. Regulation of Spemann organizer formation by the intracellular kinase Xgsk-3
25. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
26. Activation of the Wnt signaling pathway: A molecular mechanism for lithium action
27. β-Catenin is a target for the ubiquitin-proteasome pathway
28. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin
29. Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and β-catenin
30. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β
31. Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of β-catenin
32. Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3 β
33. Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3β regulates its stability
34. Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly
35. The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cell
36. A GSK3β phosphorylation site in axin modulates interaction with β-catenin and Tcf-mediated gene expression
37. Binding of the adenomatous polyposis coli protein to microtubules increases microtubule stability and is regulated by GSK3β phosphorylation
38. A versatile transcriptional effector of Wingless signaling
39. Curbing the nuclear activities of β-catenin. Control over Wnt target gene expression
40. Wnt signalling: Pathway or network?
41. GSK3, a master switch regulating cell-fate specification and tumorigenesis
42. Biochemical interactions in the wnt pathway
43. Formation of protein kinase recognition sites by covalent modification of the substrate. Molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3
44. Identification of multifunctional ATP citrate-lyase kinase as the α-isoform of glycogen synthase kinase-3
45. ATP citrate-lyase and glycogen synthase kinase-3β in 3T3-L1 cells during differentiation into adipocytes
46. 212: Potential role for DYRK as a glycogen synthase kinase 3-priming kinase
47. A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression
48. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation
49. Crystal structure of glycogen synthase kinase 3β: Structural basis for phosphate-primed substrate specificity and autoinhibition
50. Structure of GSK3β reveals a primed phosphorylation mechanism
51. Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue
52. Regulation of the protein kinase activity of Shaggy (Zeste-white3) by components of the wingless pathway in Drosophila cells and embryos
53. Differential regulation of glycogen synthase kinase 3β by insulin and Wnt signaling
54. Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1
55. Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification
56. Casein kinase 2 associates with and phosphorylates dishevelled
57. Casein kinase I transduces Wnt signals
58. Casein kinase I epsilon in the wnt pathway: Regulation of β-catenin function
59. A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and β-catenin
60. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and β-catenin signaling pathways
61. Insulin-like growth facfor 1 regulates the location, stability, and transcriptional activity of β-catenin
62. Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation
63. Drosophila shaggy kinase and rat glycogen synthase kinase-3 have conserved activities and act downstream of Notch
64. Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
65. Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation
66. Further evidence that the inhibition of glycogen synthase kinase-3β by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216
67. 216 phosphorylation of glycogen synthase kinase-3β in cellular and animal models of neuronal degeneration
68. Transient increases in intracellular calcium result in prolonged site-selective increases in tau phosphorylation through a glycogen synthase kinase 3β-dependent pathway
69. The novel tyrosine kinase ZAK1 activates GSK3 to direct cell fate specification
70. The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells
71. Specificity and mechanism of action of some commonly used protein kinase inhibitors
72. Control of p70 S6 kinase by kinase activity of FRAP in vivo
73. Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution
74. Inhibition of GSK3β leading to the loss of phosphorylated MAP-1 B is an early event in axonal remodelling induced by WNT-7a or lithium
75. Glycogen synthase kinase 3β phosphorylation of microtubule-associated protein 1B regulates the stability of microtubules in growth cones
76. Glycogen synthase kinase-3 regulates presenilin 1 C-terminal fragment levels
77. Sequential phosphorylation by mitogen-activated protein kinase and glycogen synthase kinase 3 represses transcriptional activation by heat shock factor-1
78. Transcriptional activity of heat shock factor 1 at 37°C is repressed through phosphorylation on two distinct serine residues by glycogen synthase kinase 3 and protein kinases Cα and Cζ
79. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity
80. Negative regulation of Jun/AP-1: Conserved function of glycogen synthase kinase 3 and the Drosophila kinase shaggy
81. Glycogen synthase kinase 3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells
82. Binding to cadherins antagonizes the signaling activity of β-catenin during axis formation in Xenopus
83. An in vivo structure-function study of armadillo, the β-catenin homologue, reveals both separate and overlapping regions of the protein required for cell adhesion and for wingless signaling
84. Wnt-1-dependent regulation of local E-cadherin and alpha N-catenin expression in the embryonic mouse brain
85. Interaction of glycogen synthase kinase 3β with the DF3/MUC1 carcinoma-associated antigen and β-catenin
86. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation
87. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
88. Oncogenic Ras-mediated cell growth arrest and apoptosis are associated with increased ubiquitin-dependent cyclin D1 degradation
89. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
90. Estrogen induction of the cyclin D1 promoter: Involvement of a cAMP response-like element
91. Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase
92. Growth hormone regulates phosphorylation and function of CCAAT/enhancer-binding protein β by modulating Akt and glycogen synthase kinase-3
93. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
94. Quail embryo fibroblasts transformed by four v-myc-containing virus isolates show enhanced proliferation but are non tumorigenic
95. Sequence curiosity in v-myc oncogene
96. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas
97. Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas
98. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo
99. Ras enhances Myc protein stability
100. Glycogen synthase kinase-3 inhibits the DNA binding activity of NFATc
101. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3
102. Glycogen synthase kinase 3β negatively regulates both DNA-binding and transcriptional activities of heat shock factor 1
103. Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance
104. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB
105. MSK1 is required for CREB phosphorylation in response to mitogens in mouse embryonic stem cells
106. Common pathway for the ubiquitination of IκBα, IκBβ, and IκBε mediated by the F-box protein FWD1
107. The selective and inducible activation of endogenous PI 3-kinase in PC12 cells results in efficient NGF-mediated survival but defective neurite outgrowth
108. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway
109. Glycogen synthase kinase-3β facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium
110. Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death
111. Role of glycogen synthase kinase-3β in neuronal apoptosis induced by trophic withdrawal
112. Wnt-1 signaling inhibits apoptosis by activating β-catenin/T cell factor-mediated transcription
113. EGF receptor/rolled MAP kinase signalling protects cells against activated Armadillo in the Drosophila eye
114. Insulin resistance, impaired glucose tolerance and non-insulin-dependent diabetes, pathologic mechanisms and treatment: Current status and therapeutic possibilities
115. New approaches in the treatment of type 2 diabetes
116. Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice
117. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription
118. Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphoenolpyruvate carboxykinase gene expression
119. Stimulatory effect of lithium on glucose transport in rat adipocytes is not mediated by elevation of IP1
120. The role of glycogen synthase kinase 3β in insulin-stimulated glucose metabolism
121. Inhibition of glycogen-synthase kinase 3 stimulates glycogen synthase and glucose transport by distinct mechanisms in 3T3-L1 adipocytes
122. Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action
123. Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/phosphatidylinositol 3-kinase pathway
124. Linking colorectal cancer to Wnt signaling
125. Wnt signaling and cancer
126. Activation of a novel proto-oncogene, Frat1, contributes to progression of mouse T-cell lymphomas
127. Exogenous expression of β-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest
128. Siah-1 mediates a novel β-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein
129. Siah-1, SIP, and Ebi collaborate in a novel pathway for β-catenin degradation linked to p53 responses
130. Intestinal polyposis in mice with a dominant stable mutation of the β-catenin gene
131. Frequent nuclear/cytoplasmic localization of β-catenin without exon 3 mutations in malignant melanoma
132. Apoptosis in neurodegenerative disorders
133. The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases
134. Neurodegenerative tauopathies
135. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localization of the kinase
136. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau
137. Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons
138. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding
139. Tau in paired helical filaments is functionally distinct from fetal tau: Assembly incompetence of paired helical filament-tau
140. Indirubins inhibit glycogen synthase kinase-3 β and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
141. β-Catenin signalling modulates proliferative potential of human epidermal keratinocytes independently of intercellular adhesion
142. Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation
143. Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors
144. Survival-promoting activity of inhibitors of cyclin-dependent kinases on primary neurons correlates with inhibition of c-Jun kinase-1
145. G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis
146. Apoptosis of central and peripheral neurons can be prevented with cyclin-dependent kinase/mitogen-activated protein kinase inhibitors
147. Modulation of Wnt signaling by Axin and Axil